Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (68)

View All

Latest Posts

About This Stock More About This Stock
Top Five Weekend Stock Stories - May 19, 2019
Article By: The Fly
Sunday, May 19, 2019 8:37 PM EDT
Catch up on the weekend's top five stories with this list compiled by The Fly...
In this article: BWA, DIS, JWN, MCD, SCHW, TSN, REGN, AMAT, GOOG, TTWO, GOOGL, TPR, LGF-A
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga
Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich
Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read
Leaders Reporting Tomorrow
Article By: Bespoke Investment Group
Tuesday, February 5, 2019 5:35 PM EDT
Among the companies set to report earnings on Wednesday are Regeneron Pharmaceuticals, Chipotle, and Spire.
In this article: REGN, CMG, SR
Read
13 Monster Stock Market Predictions For The Week Of January 28
Article By: Michael J. Kramer
Sunday, January 27, 2019 12:46 PM EDT
The week of January 28 will definitely not be a dull one with a monster week for earnings from tech titans and more.
In this article: NKE, ACAD, REGN, GILD, MU, NFLX, GOOGL, SQ, ROKU, BB, BABA, JD
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $REGN

No tweets yet!

$REGN

Comments Status Updates
Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner • 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments